These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28528827)

  • 21. Diffuse multiple sclerosis and chronic central serous chorioretinopathy: pitfall not to ignore.
    Milazzo S; Drimbea A; Betermiez P; Al Fayez S; Bremond-Gignac D
    Pract Neurol; 2013 Jun; 13(3):200-3. PubMed ID: 23487813
    [No Abstract]   [Full Text] [Related]  

  • 22. Central serous chorioretinopathy in a patient with congenital retinal macrovessel.
    Kumar V; Ghosh B; Raina U; Goel N
    Can J Ophthalmol; 2009 Dec; 44(6):e57. PubMed ID: 20051997
    [No Abstract]   [Full Text] [Related]  

  • 23. Increased fundus autofluorescence related to outer retinal disruption.
    Freund KB; Mrejen S; Jung J; Yannuzzi LA; Boon CJ
    JAMA Ophthalmol; 2013 Dec; 131(12):1645-9. PubMed ID: 24136134
    [No Abstract]   [Full Text] [Related]  

  • 24. Central serous chorioretinopathy in young adults.
    Pryds A; Larsen M; Barbazetto I; Yannuzzi L
    Acta Ophthalmol; 2012 Aug; 90(5):e404-5. PubMed ID: 23043628
    [No Abstract]   [Full Text] [Related]  

  • 25. Annular Lesions and Catenary Forms in Chronic Central Serous Chorioretinopathy.
    Dansingani KK; Balaratnasingam C; Mrejen S; Inoue M; Freund KB; Klancnik JM; Yannuzzi LA
    Am J Ophthalmol; 2016 Jun; 166():60-67. PubMed ID: 27021439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central serous chorioretinopathy in Susac syndrome.
    Artunay O; Sengul A; Sonmezay E; Gaffarli E; Ertugay CK
    J Neuroophthalmol; 2015 Jun; 35(2):182-4. PubMed ID: 25786202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pachychoroid neovasculopathy: aspect on optical coherence tomography angiography.
    Azar G; Wolff B; Mauget-Faÿsse M; Rispoli M; Savastano MC; Lumbroso B
    Acta Ophthalmol; 2017 Jun; 95(4):421-427. PubMed ID: 27597633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subretinal dot-like precipitates and yellow material in central serous chorioretinopathy.
    Maruko I; Iida T; Ojima A; Sekiryu T
    Retina; 2011 Apr; 31(4):759-65. PubMed ID: 21052035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anxious man with blurred vision.
    Belmekhtar A; Rajae D
    Pan Afr Med J; 2015; 20():361. PubMed ID: 26185553
    [No Abstract]   [Full Text] [Related]  

  • 30. Half-fluence photodynamic therapy in acute central serous chorioretinopathy.
    Smretschnig E; Ansari-Shahrezaei S; Moussa S; Glittenberg C; Krebs I; Binder S
    Retina; 2012; 32(10):2014-9. PubMed ID: 22466482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retinal microstructural abnormalities in central serous chorioretinopathy and polypoidal choroidal vasculopathy.
    Ooto S; Tsujikawa A; Mori S; Tamura H; Yamashiro K; Otani A; Yoshimura N
    Retina; 2011 Mar; 31(3):527-34. PubMed ID: 20890237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biometric characteristics of eyes with central serous chorioretinopathy.
    Oh JH; Oh J; Togloom A; Kim SW; Huh K
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1502-8. PubMed ID: 24550360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy.
    Maruko I; Iida T; Sugano Y; Furuta M; Sekiryu T
    Retina; 2011 Oct; 31(9):1921-7. PubMed ID: 21878850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic and therapeutic challenges.
    Wong IY; Lam JK; Cebulla CM
    Retina; 2013 May; 33(5):1076-80. PubMed ID: 23296050
    [No Abstract]   [Full Text] [Related]  

  • 35. BASELINE SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AS A PREDICTOR OF VISUAL OUTCOME AND RECURRENCE FOR CENTRAL SEROUS CHORIORETINOPATHY.
    Lee H; Lee J; Chung H; Kim HC
    Retina; 2016 Jul; 36(7):1372-80. PubMed ID: 26702841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel marker in acute central serous chorioretinopathy: thiol/disulfide homeostasis.
    Altinkaynak H; Kurkcuoglu PZ; Caglayan M; Yorgun MA; Yuksel N; Kosekahya P; Koca C; Toklu Y
    Int Ophthalmol; 2018 Feb; 38(1):175-181. PubMed ID: 28108906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis and interventions for central serous chorioretinopathy: review and update.
    Quin G; Liew G; Ho IV; Gillies M; Fraser-Bell S
    Clin Exp Ophthalmol; 2013 Mar; 41(2):187-200. PubMed ID: 22788713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of morphologic alterations by spectral-domain optical coherence tomography before and after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy.
    Shinojima A; Kawamura A; Mori R; Fujita K; Yuzawa M
    Retina; 2011 Oct; 31(9):1912-20. PubMed ID: 21952105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraocular gnathostomiasis and central serous chorioretinopathy.
    Moynihan V; Bhikoo R; Tay-Kearney ML
    Clin Exp Ophthalmol; 2020 Sep; 48(7):1005-1007. PubMed ID: 32506596
    [No Abstract]   [Full Text] [Related]  

  • 40. Intravitreal bevacizumab injection for central serous chorioretinopathy.
    Lim SJ; Roh MI; Kwon OW
    Retina; 2010 Jan; 30(1):100-6. PubMed ID: 20010322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.